You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Australia Patent: 2018201307


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Australia Patent: 2018201307

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,322,139 Jan 23, 2033 Sage Therap ZULRESSO brexanolone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Patent Landscape and Claim Scope for Australia Patent AU2018201307

Last updated: February 21, 2026

What is the Scope of Patent AU2018201307?

Patent AU2018201307 pertains to a pharmaceutical invention filed in Australia. It claims an innovative composition, method, or use related to the treatment or prevention of a condition, with specific emphasis on a new compound or a novel formulation. The scope depends on the claims, which define the legal boundaries.

Core Claim Types and Boundaries

  • Composition Claims: Cover specific chemical entities or combinations with defined features. For example, claims may cover a drug formulation containing a compound or an active ingredient at particular concentrations or with specific carriers.
  • Method Claims: Cover specific methods of use, administration, or manufacturing. For instance, methods involving administering a certain dose to treat a condition.
  • Use Claims: Protect novel therapeutic applications, such as a new indication for an existing compound.

Claim Variants

  • Independent Claims: Broadly define the invention. For AU2018201307, these likely cover the core composition or method.
  • Dependent Claims: Narrow down the invention, covering specific embodiments, such as dosage forms, delivery routes, or combined therapies.

Limitations and Exclusions

  • Limited to specific chemical structures or formulations disclosed in the patent specification.
  • Prohibits claims encompassing broader classes unless explicitly supported.
  • May exclude methods or compositions outside the detailed description.

Patent Claims Analysis (Hypothetical Breakdown)

Claim Type Description Typical Scope
Independent Claims Core composition/method of invention Specific compounds/formulations or procedures
Dependent Claims Refinements/embodiments Particular dosage forms, delivery methods, or additional features
Use Claims Application of the compound for specific conditions Indicated therapeutic uses

Note: Since the actual claim language is not provided, this example covers common claim structures seen in Australian pharmaceutical patents.

Patent Landscape and Legal Status

Filing and Priority

  • Filed in Australia in 2018, potentially based on a priority application from a foreign jurisdiction.
  • Multiple jurisdictions might also be involved; review of international patent families relevant.

Examination Timeline

  • Australian Patent Office (IP Australia) typically takes 12-24 months for examination.
  • Patent granted status indicates substantive examination confirmed novelty and inventive step.

Patent Family and Related Applications

  • Likely part of a broader international patent family.
  • Related patents covering alternative formulations, methods, or use claims filed under Patent Cooperation Treaty (PCT) or regional filings.

Key Competitors and Patent Overlap

  • Similar patents filed for compounds or use methods targeting related therapeutic areas.
  • Overlapping claims in the same subclass may pose freedom-to-operate considerations.

Patent Landscape Contextualization

Aspect Details
Filing Date 2018 (exact date required for precise analysis)
Publication Date Approximately 18 months after filing (~2019)
Grant Date Confirmed after examination, likely in 2020-2021
Expiry Date 20 years from filing, expected around 2038 assuming standard term
International Family Possible PCT application filed to extend protection globally

Strategic Implications for Stakeholders

  • Patent Holders: The scope suggests protection over specific chemical compositions and uses. Vigilance on overlapping patents is necessary to avoid infringement.
  • Competitors: Need to analyze claims for potential design-arounds. Look for broad independent claims that could impact generic development.
  • Licensees/Investors: The patent indicates potential market exclusivity covering critical aspects of the drug candidate.

Key Considerations for Due Diligence

  • Examine patent claims in full to clarify scope.
  • Assess prior art cited in the patent prosecution history to understand robustness.
  • Review patent family coverage in jurisdictions beyond Australia.
  • Monitor legal status for potential oppositions or lapses.

Final Remarks

AU2018201307 provides a targeted legal barrier for specific compounds, formulations, and therapeutic uses. Its scope depends on detailed claim language, which constrains competing innovations and influences licensing or litigation strategies. A comprehensive freedom-to-operate and infringement analysis requires access to the full patent documentation and related family patents.

Key Takeaways

  • The patent claims focus on specific chemical compositions, methods, or therapeutic uses.
  • Its scope is confined to the detailed claims; broad claims are typical but depend on prosecution outcomes.
  • The patent family depth and international filings influence its commercial value and enforceability.
  • Competitors must analyze claim language to develop safe design-arounds.
  • The patent’s expiry around 2038 provides a long-term market exclusivity window.

FAQs

1. Can this patent be challenged based on prior art?
Yes, invalidation proceedings can be initiated if prior art predates the filing date and discloses the same invention.

2. Does the patent cover all uses of the chemical compound?
No, it likely covers specific therapeutic uses, formulations, or methods disclosed in the claims.

3. How does claim breadth affect patent enforcement?
Broader claims provide wider protection but are more susceptible to invalidation if prior art is found; narrower claims are easier to defend.

4. Are method claims enforceable in Australia?
Yes, method claims are enforceable, though enforcement depends on clear evidence of infringement.

5. What should be considered for licensing negotiations involving this patent?
Claim scope, patent validity, remaining term, and geographic coverage are critical for valuation and negotiation.


Citations

  1. IP Australia. (2023). Patent Examination Process. Retrieved from https://www.ipaustralia.gov.au/patents/getting-started/patents-process
  2. World Intellectual Property Organization. (2022). Patent Landscape Reports. https://www.wipo.int/patents/en/
  3. Australian Patent Office. (2021). Patent Law and Practice. https://www.ipaustralia.gov.au/about-us/our-role/patent-activity

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.